Manu Chakravarthy

Manu Chakravarthy

Company: Carmot Therapeutics

Job title: Chief Scientific & Medical Officer


Roundtable Discussion: Navigating Improvement of Weight Loss Maintenance When Taking GLP-1s 3:30 pm

Discussing adherence to maintain weight loss in patients that may be resistant to lifelong treatment Exploring methods to alongside treatment with GLP-1s to ensure weight loss is maintainedRead more

day: Conference Day Two

Driving Durability of GLP-1-Based Therapeutics to Improve Maintenance of Weight Loss & Considering Treatments Alongside GLP-1s 3:00 pm

Exploring the resistance of patients to taking lifelong medication and considering the need for more durable GLP-1 treatments Delving into the newest innovations in evolving treatments that last longer to hear about techniques such as combinations that are leading to promising results Considering the possibility of a shortened treatment in the future to understand what…Read more

day: Conference Day Two

Panel Discussion: Exploring the Weight Independent Benefits of GLP-1 3:00 pm

Evaluating the impact of GLP-1s: are all observed benefits attributable to weight reduction or are other mechanisms in play? Considering how co-morbidities should be addressed from a clinical and commercial strategy perspective Clarifying uncertainties related to expanding into numerous new therapeutic areasRead more

day: Conference Day One

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.